$NBIO Nascent Biotech Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Nascent Biotech Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Nascent Biotech Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Nascent Biotech Inc. for free.
IRS Number: 450612715
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NBIO
Company Address: 623 17TH STREET, SUITE 4 VERO BEACH 32960
Phone number: 612-961-5656
Market Capitalization: $6.97M
Prev close: $0.30
Average Daily Volume: 5,342
Days Low: $0.32
Year Low: $0.05
Year High: $1.02
Nascent Biotech Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 06 2021 | NBIO | Nascent Biotech In ... | Karas Douglas John | Buy | J | 0.07 | 83,334 | 5,833 | 773,224 | 689.9 K to 773.2 K (+12.08 %) | |
| Apr 06 2021 | NBIO | Nascent Biotech In ... | Carrick Sean | President & CEO | Buy | J | 0.06 | 1,620,000 | 98,820 | 15,673,731 | 14.1 M to 15.7 M (+11.53 %) |
| Apr 06 2021 | NBIO | Nascent Biotech In ... | Carrick Sean | President & CEO | Buy | J | 0.06 | 1,250,000 | 75,000 | 14,048,731 | 12.8 M to 14 M (+9.77 %) |
| Apr 06 2021 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.06 | 810,000 | 49,410 | 10,368,077 | 9.6 M to 10.4 M (+8.47 %) |
| Apr 06 2021 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.06 | 1,000,000 | 60,000 | 9,558,077 | 8.6 M to 9.6 M (+11.68 %) |
| Jan 11 2021 | NBIO | Nascent Biotech In ... | Karas Douglas John | Buy | J | 0.05 | 108,460 | 4,989 | 689,890 | 581.4 K to 689.9 K (+18.65 %) | |
| Jan 11 2021 | NBIO | Nascent Biotech In ... | Karas Douglas John | Buy | J | 0.05 | 350,000 | 17,500 | 581,490 | 231.5 K to 581.5 K (+151.19 %) | |
| Jan 11 2021 | NBIO | Nascent Biotech In ... | Karas Douglas John | Buy | J | 0.07 | 71,430 | 5,000 | 231,490 | 160.1 K to 231.5 K (+44.63 %) | |
| Jan 11 2021 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.05 | 1,442,000 | 66,476 | 8,558,077 | 7.1 M to 8.6 M (+20.26 %) |
| Jan 11 2021 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.07 | 127,970 | 8,958 | 7,116,077 | 7 M to 7.1 M (+1.83 %) |
| Jan 11 2021 | NBIO | Nascent Biotech In ... | Carrick Sean | President & CEO | Buy | J | 0.05 | 2,884,000 | 132,952 | 12,803,731 | 9.9 M to 12.8 M (+29.07 %) |
| Jan 11 2021 | NBIO | Nascent Biotech In ... | Carrick Sean | President & CEO | Buy | J | 0.10 | 218,715 | 21,872 | 9,919,731 | 9.7 M to 9.9 M (+2.25 %) |
| Jul 02 2020 | NBIO | Nascent Biotech In ... | Price Brandon | Senior VP Business ... | Buy | J | 0.10 | 534,000 | 53,400 | 7,002,328 | 6.5 M to 7 M (+8.26 %) |
| Jul 02 2020 | NBIO | Nascent Biotech In ... | Price Brandon | Senior VP Business ... | Buy | J | 0.10 | 2,821,830 | 282,183 | 6,468,328 | 3.6 M to 6.5 M (+77.38 %) |
| Jul 02 2020 | NBIO | Nascent Biotech In ... | HOLDEN LOWELL THOMAS | CFO | Buy | J | 0.10 | 534,000 | 53,400 | 6,988,107 | 6.5 M to 7 M (+8.27 %) |